Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 16 of 16 for “"Generic drugs."”.
-
An Analysis of Trends of Generic Drugs and Biologic Prices in the U.S.
… problem for the US healthcare system. Generic and biosimilar market competition reduces drug and biologic prices, results in substantial savings, and improves patient access and outcomes. As the costs of healthcare and prescription drugs continue to rise, the discussion about drug …
-
Primary care physicians' perspectives on the Ontario Drug Benefit Program (ODB).
… governments to publicly fund prescription drugs when delivered in the hospital. This coverage does not continue once individuals are discharged under the terms of the CHA. Governments do provide additional public coverage for drugs outside of the hospital for specific groups. The Ontario …
-
Three Essays on Regulation in Healthcare and Pharmaceutical Markets
… across different types of the hospitals and drugs.</p> <p>The dissertation consists of three essays. The first essay proposes a propensity score matching-difference in difference framework of program evaluation of Value Based Purchasing program. This framework first applies the propensity …
-
A comprehensive guide to the three biosimilar markets (Europe, US, Japan) and the regulatory pathways
Generics in the pharmaceutical industry have been instrumental in reducing overall healthcare cost and allowing for greater dispersal of life saving drugs to the general population. The Hatch-Waxman Act of 1984 played a critical role in changing the landscape of the pharmaceutical industry and …
-
Technological learning and the evolution of the Indian pharmaceutical and biopharmaceutical sectors
… low R&D investments, "copying" on-patent drugs (legal in India if a novel process is found) and manufacturing off-patent, generic drugs. Yet, some firms are innovating in drug discovery and development and the total number of firms is among the most numerous and export-oriented in the …
-
Profit incentives and technological change
… of (potential) market size on entry of new drugs and pharmaceutical innovation. Focusing on exogenous changes driven by U.S. demographic trends, we find a large effect of potential market size on the entry of non-generic drugs and new molecular entities. These effects are generally robust to …
-
Determinants Of Drug Utilisation During Childhood
… is a neglected area in terms of rational use of drugs. Wide differences have been observed in children’s exposure to drugs between and within countries and regions. The aim of the current thesis is to investigate the determinants of drug prescription in paediatrics. Pharmacoepidemiology and the …
-
Market Heterogeneity and Drug Innovation
… measures (e.g., new molecules, new non-generic drugs, new patents). I propose and investigate an extended Induced Innovation Hypothesis (eIIH) which posits how non-size characteristics of markets or "market heterogeneity" (e.g., compositional structure, R&D riskiness) together with …
-
In Defense of the Middleman: Quality Failures in the Generic Pharmaceutical Market
… retailers, discipline quality in the market for generic prescription drugs. Consumers are uniquely uninformed about quality in this market, since generic drugs are conventionally assumed to be interchangeable. As in many settings where consumers lack product information, they implicitly rely on …
-
Los medicamentos genéricos, entre la propiedad privada y la salud pública
… availability of safe, effective, and quality drugs care for diseases and conditions that affect the community. The high costs associated with the development and commercialization of new molecules, are the source of high drug prices, which increase drug costs borne by society. The existence of …
-
Topics in odds ratio estimation in the case-control studies and the bioequivalence testing in the crossover studies.
… plays an important role in the development of generic drugs. The current FDA criteria is not flexible with respect to highly variable drugs, and this characteristic has caused many good drugs to be rejected. Most often in the literature, we find studies examining the sample size or the …
-
The likely impact of trade-related aspects of intellectual property rights (TRIPS) in Mozambique : the case of anti-malarial drugs
… from patent protection in order to produce drugs at reduced prices and hence contribute to the improvement of public health. But now any Member State must comply with these minimum standards since failure to do so will result to the WTO dispute settlement system. No extensive review of the …
-
Factors Influencing Physicians' Willingness to Substitute Generics For Brand-Names when Prescribing Antimicrobial Drugs
Physicians often continue to prescribe brand-name drugs to their patients even when less expensive generic equivalents are available. In a 1994 study, Judith Hellerstein advances two hypotheses to explain this behavior. First, doctors may consciously conclude that certain brand-name drugs impart a …
-
Demand Forecasting In Manufacturing Pharmaceutical Small and Medium Enterprise’s (SME’s) In Ghana
… and for drug innovation; from manufacturing of drugs till the time it reaches the customer. Forecasting’s role in the pharmaceutical sector is to inform both clinical and non-clinical decisions and determine how a drug will perform commercially. This study investigate how Mpharma SMEs in Ghana …
-
An analysis of the impact of generic medicine reference pricing in a sector of the South African private healthcare insurance industry
… to exceed economic growth and inflation. Generic medicines play an important role in limiting this expenditure, and consequently there is an international drive to implement pro - generic policies particularly in high income countries. One such policy is generic medicine reference pricing …